Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Researchers Brines and Cerami proposed that by activating the Innate Repair Receptor pathway, ARA-290 may successfully substitute for a relative deficiency of EPO production in damaged tissues in laboratory models, potentially paving the way for expanded investigation into tissue repair mechanisms in these experimental settings
The lab report is the authority for a batch Identity, purity, appearance, and storage for the material we ship come from the lab report and label - not from these papers
Your body already uses peptides to regulate many functions
Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure, or prevent any disease or condition
Common mild effects: Temporary flushing or warmth at infusion site (typically brief) Mild headache in some patients at higher doses Rare nausea Important clinical considerations: Patients with asthma should be evaluated prior to IV glutathione because inhaled glutathione has been associated with bronchospasm in some asthmatic individuals
